ReleaseWire Connect

As we move into a new phase of the pandemic, many leaders are looking at the success stories of other countries as inspiration for their own strategy. Places like New Zealand and the Isle of Man are shining examples of how adopting a Zero Covid strategy has allowed them to return to a normal way of life. In the US, with a new administration, a fresh take on battling the virus and with vaccination programs underway, this could result in the United States getting on track and tackling the pandemic.

As the Pfizer & BioNTech coronavirus vaccine got the go-ahead from the FDA and the American population begins to become immunized, we hope that 2021 will bring a welcomed sigh of relief as the world can begin to return to normal.

Whilst the COVID 19 pandemic has strained a multitude of industries over the past year, others have thrived. At a compound annual growth rate of 5.0%, the global biotechnology services industry is forecast to grow from $142.92 billion in 2019 to $4150.06 billion in 2020.

Pharmaceutical companies rely heavily on their research and development department to ensure they are discovering and developing new products, medicines, vaccines and medical devices. This ensures they stay in the black and out of the red.

Life sciences companies across the United States, from east to west coast are searching for business-critical talent to get behind life-saving medicines and devices and ensure the country remains in the black and out of the red. As we head into the new year, 2021 is also expected to be a year of disruption, however, there is hope on the horizon and this is largely due to the rapid new technologies which have enabled the production of life-saving vaccines for the COVID-19 pandemic.

Prior to 2020, the life sciences industry in Germany is no stranger to disruption. The introduction of new technologies has forced many companies to increase their adaptations and bring on a workforce that can manage the changes in 3D printing, gene editing, artificial intelligence and big data.

A career in pharmacovigilance can have an immense impact on the healthcare industry as a whole. Doctors are expected to take part in a pharmacovigilance system to report on the adverse reactions and events to their patients caused by prescribed drugs.

Established in 2012, EPM Scientific have since become the most, well regarded life sciences recruitment agency in the US. Their reach spans 60+ countries globally from Europe, Asia and North America and having built a network of one million mid-to-senior professionals the firm have a levelled perspective on the local and global markets.

EPM Scientific are leading the way in ensuring US companies have peace of mind when it comes to their biggest business issue: talent acquisition.

Biometrics is the future of healthcare. They are the physical or behavioural human characteristics that identify a person and are being used daily to protect our personal, medical information.